title: Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Medications and Techniques.
abstract: Over the past 2 decades, it increasingly has been recognized that endoscopic retrograde cholangiopancreatography (ERCP) is the most predictable provocateur of acute pancreatitis, with an incidence of more than 15% in high-risk patients. For this reason, there has been considerable interest in the effect of periprocedural drug administration as well as different ERCP techniques on both the incidence and severity of post-ERCP pancreatitis. Although many agents and techniques have shown promise in small clinical studies, the majority of these have failed to yield consistent benefit in larger randomized patient groups. This review summarizes the data on medications and ERCP techniques that have been studied for the prevention of post-ERCP pancreatitis.
authors.affiliation: Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, Virginia. Electronic address: ayw7d@virginia.edu.
authors.forename: Andrew Y
authors.initials: AY
authors.lastname: Wang
authors.affiliation: Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, Virginia.
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Strand
authors.affiliation: Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, Virginia.
authors.forename: Vanessa M
authors.initials: VM
authors.lastname: Shami
mesh_terms: D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D010195:Pancreatitis / Q000517:prevention & control*; D019990:Perioperative Care / Q000379:methods*
keywords: ERCP; Medications; Pancreatitis; Prevention; Stents